Michael Lee Ham, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2820 N Glassford Hill Rd, Ste 101, Prescott Valley, AZ 86314 Phone: 928-775-5606 Fax: 928-772-4999 |
News Archive
Arthrosurface, Inc., a developer of novel joint technologies, has received FDA 510(k) clearance for the KISSloc Suture System, a mini plate and suture implant intended for the correction of a Hallux Valgus deformity.
Heart attacks during the COVID-19 pandemic were more likely to result in heart failure compared with heart attacks one year earlier, according to research presented today at Heart Failure 2021, an online scientific congress of the European Society of Cardiology.
TaiGen Biotechnology Co., Ltd. announced today the presentation of Phase I and preclinical data for TG-0054, the Company's chemokine receptor CXCR4 antagonist and a novel, potent stem cell mobilizer, at the ASH Annual Meeting held in New Orleans, the US, from December 5 to 8, 2009.
Jonathan Stamler, MD, Director of the Institute for Transformative Molecular Medicine and the Robert S. and Sylvia K. Reitman Family Foundation Distinguished Chair in Cardiovascular Innovation at the Case Western Reserve University and University Hospitals Harrington-McLaughlin Heart & Vascular Institute, has recently received a $4.7 million contract from the Defense Advanced Research Projects Agency to fund the development of a new class of drugs that will selectively dilate blood cells under hypoxia (lack of oxygen in the body's tissues) and thereby enhance soldiers' performance at high altitude.
› Verified 4 days ago